Acromegaly Management

This episode breaks down the clinical management matrix for acromegaly, providing an advanced roadmap for endocrinologists managing growth hormone hypersecretion. We review transsphenoidal surgery guidelines, post-operative remission metrics, and tailored medical management algorithms. Discover how to strategically navigate first and second generation somatostatin receptor ligands, dopamine agonists, and growth hormone receptor antagonists. Finally, we dissect mandatory transition indicators, critical safety monitoring for drug-induced toxicities, and lifelong surveillance protocols for systemic comorbidities.